ASCO to shine light on CAR-T developments – pharmaphorum
pharmaphorum |
ASCO to shine light on CAR–T developments
pharmaphorum Novartis and Kite have CAR-T (chimeric antigen receptor T–cell) therapies under review in the US for blood cancers, and the conference in Detroit early next month may shed more light on this potentially revolutionary therapy class. CAR-T therapies … |
